shortagewatch

Home / Companies / Sawai

Company family · HQ JP

Sawai: medicine shortages

4887 · Tokyo

As of 2 Nov 2026, 148 Sawai products have a reported shortage across 1 countries, covering 68 medicines.

Products short148rank #17 of 464
Medicines68active ingredients
Countries1/16
New in 90 days27-55 vs market pace
Typical duration6 monthsmedian so far
Manufacturing22%demand-driven 20%

Where

Japan148

Which therapeutic classes

Cardiovascular system44Digestive tract and metabolism15Anti-infectives15Genito-urinary system and sex hormones11Respiratory system9Nervous system7Cancer and immune system5Dermatologicals5Musculoskeletal system4Sensory organs3

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
SawaiSawai: Manufacturing problem 32 (26%)26%Sawai: Increased demand 30 (24%)24%Sawai: Active ingredient shortage 9 (7%)7%Sawai: Regulatory or licensing 2 (2%)Sawai: Other 52 (42%)42%All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

Latest changes

All changes

No changes recorded yet. Changes are tracked from our daily snapshots.

When its current shortages began

05101520Dec: 1Jan ’25: 1Feb: 0FebMar: 1Apr: 0May: 4MayJun: 4Jul: 3Aug: 2AugSep: 4Oct: 0Nov: 3NovDec: 10Jan ’26: 6Feb: 5FebMar: 0Apr: 12May: 11MayJun: 16Jul: 16Aug: 10AugSep: 7Oct: 10Nov: 0Nov

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Sawai148

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 151 / 74Baxter: 149 / 27Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Sawai: 148 / 68Sawai

Further right: more products short. Higher: more different medicines affected.

Medicines short

Download CSV
MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Candesartan822 Oct 2026Other10/16
Montelukast521 Mar 2025Quality problem or recall13/16
Atorvastatin and Amlodipine411 Dec 2025Increased demand2/16
Lansoprazole49 Oct 2024Quality problem or recall8/16
Olmesartan Medoxomil410 Jun 2026Other5/16
Alfacalcidol311 Mar 2024Active ingredient shortage3/16
Carboplatin37 May 2024Quality problem or recall10/16
Irbesartan330 Apr 2026Other6/16
Oxybutynin315 Jul 2026Other5/16
Rosuvastatin39 Feb 2026Increased demand12/16
Theophylline37 Aug 2025Quality problem or recall3/16
Alendronic Acid211 Mar 2024Other7/16
Cefaclor24 Oct 2024Manufacturing problem4/16
Cefdinir24 Sep 2024Manufacturing problem1/16
Ceftazidime211 Mar 2024Manufacturing problem5/16
Cibenzoline27 Apr 2026Manufacturing problem1/16
Cilnidipine225 Jun 2025Manufacturing problem1/16
Cilostazol231 Aug 2026Other2/16
Deferasirox216 Jul 2026Other8/16
Famotidine220 Oct 2026Manufacturing problem4/16
Irbesartan and Amlodipine215 Sep 2026Other1/16
Manidipine231 Aug 2026Other2/16
Mexiletine219 Sep 2025Increased demand1/16
Minocycline210 Apr 2026Increased demand3/16
Propiverine228 May 2026Manufacturing problem2/16
Quazepam211 Mar 2024Quality problem or recall1/16
Rabeprazole226 Jun 2026Quality problem or recall5/16
Silodosin29 Jul 2026Other4/16
Telmisartan211 Jun 2026Manufacturing problem6/16
Telmisartan and Amlodipine215 May 2025Increased demand3/16
Terbinafine28 Jul 2025Manufacturing problem5/16
Valsartan230 Jul 2026Other7/16
tosufloxacin216 Jul 2026Quality problem or recall1/16
Ambroxol110 Apr 2026Increased demand3/16
Amitriptyline131 Aug 2026Quality problem or recall5/16
Atenolol111 Mar 2024Active ingredient shortage6/16
Betamethasone127 Apr 2026Quality problem or recall1/16
Bifonazole128 May 2026Increased demand3/16
Cefoperazone and Beta-Lactamase Inhibitor110 Apr 2026Active ingredient shortage1/16
Ceftriaxone18 Jan 2025Quality problem or recall5/16
Celecoxib19 Jul 2026Other8/16
Clindamycin14 Jun 2025Manufacturing problem4/16
Cromoglicic Acid16 Nov 2025Quality problem or recall1/16
Dienogest111 Jun 2026Manufacturing problem2/16
Dilazep131 Aug 2026Other1/16
Disopyramide118 May 2026Manufacturing problem3/16
Domperidone117 Feb 2026Increased demand5/16
Dutasteride130 Jul 2025Increased demand4/16
Erythromycin122 Jan 2026Active ingredient shortage2/16
Etodolac131 Aug 2026Other1/16
Ezetimibe115 Sep 2026Other9/16
Imatinib125 May 2026Other1/16
Itopride122 Jan 2026Manufacturing problem2/16
Letrozole110 Jun 2026Quality problem or recall6/16
Levetiracetam16 Jun 2025Increased demand9/16
Memantine18 May 2026Manufacturing problem8/16
Meropenem128 May 2026Manufacturing problem6/16
Mesalazine116 Oct 2024Increased demand11/16
Olopatadine115 May 2025Manufacturing problem2/16
Probucol125 May 2026Other1/16
Risperidone110 Nov 2025Quality problem or recall13/16
Roxithromycin122 Jan 2026Manufacturing problem3/16
Tamsulosin117 Dec 2024Manufacturing problem6/16
Tramadol and Paracetamol117 Feb 2026Increased demand5/16
Trimebutine19 Jul 2026Manufacturing problem2/16
Ubidecarenone130 Apr 2026Other1/16
Valaciclovir111 Jun 2026Other10/16
Vardenafil116 Jun 2026Other6/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.